Robert Rzemiński – Chairman of the Supervisory Board

A graduate of the Faculty of Chemistry at the University of Wrocław with a Master’s degree in Chemistry. He has been professionally involved in the pharmaceutical industry for over twenty years. Robert Rzemiński has experience in production, QA&QC, product development, clinical research, registration, marketing of medicinal products, capital investments and M&A in healthcare areas. Between 1997 and 2004 he was associated with Jelfa Pharmaceutical Company S.A. and from 2001 to 2004, he served as Member of the Management Board of that company. From 2005 to 2009 he was a Member of the Management Board and President of OINPHARMA Sp. z o. o.
In the years 2007-2014, he was an investment partner and a Member of the Management Board of MCI.BioVentures capital fund, where he was responsible for numerous investments in life science companies. Furthermore, he was a Member of the Management Board of Genomed S.A. and Vice-President of the Management Board of Biotech Varsovia Pharma. He also served functions in several other biotech companies.
 Founder and investor in IT companies operating in the pharmaceutical industry.
Robert Rzemiński is currently the President of the Management Board of Pharmtek CG Sp. z o.o.